Sign inCreate account

Report workspace tools

NCT00990665COMPLETEDanonymous

Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study

Sponsor

Source record

Abbott Medical Devices

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

Heart Failure

Indication / condition

AI-normalized

Heart Failure

Intervention

Source record

CRT-D and LV lead (Quartet™ lead and Promote Q® device system)

Source & freshness

Source record

NCT ID

NCT00990665

Original source

ClinicalTrials.gov

Source last updated

Feb 27, 2019

Ingested at

May 30, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT00990665

Title

Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study

Sponsor

Abbott Medical Devices

Status

COMPLETED

Phase

NA

Condition raw

Heart Failure

Condition normalized

Heart Failure

Modality raw

Heart Failure

Modality normalized

medical device

Target raw

Heart Failure

Target normalized

Heart Failure

Interventions

CRT-D and LV lead (Quartet™ lead and Promote Q® device system)

Public preview

Source record

The Promote Q CRT-D and Quartet LV lead study, sponsored by Abbott Medical Devices, aimed to evaluate the safety and efficacy of a new cardiac resynchronization therapy device in patients with heart failure. The study enrolled 178 participants and was completed in July 2012.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT00990665

Status

COMPLETED

Phase

NA

Sponsor

Abbott Medical Devices

Executive brief

Investment-Ready Snapshot

The Promote Q CRT-D and Quartet LV lead study, sponsored by Abbott Medical Devices, aimed to evaluate the safety and efficacy of a new cardiac resynchronization therapy device in patients with heart failure. The study enrolled 178 participants and was completed in July 2012.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedFeb 27, 2019
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT00990665

Indication

Heart Failure

Modality

medical device

Target

Heart Failure

Intervention

CRT-D and LV lead (Quartet™ lead and Promote Q® device system)

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.